Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model

We aimed to create a prognostic model in metastatic melanoma based on independent prognostic factors in 321 patients receiving interleukin-2 (IL-2)-based immunotherapy with a median follow-up time for patients currently alive of 52 months (range 15–189 months). The patients were treated as part of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, H, Bastholt, L, Geertsen, P, Christensen, I J, Larsen, S, Gehl, J, von der Maase, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361564/
https://www.ncbi.nlm.nih.gov/pubmed/16052222
http://dx.doi.org/10.1038/sj.bjc.6602702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361564/
https://www.ncbi.nlm.nih.gov/pubmed/16052222
http://dx.doi.org/10.1038/sj.bjc.6602702

Ejemplares similares